(UroToday.com) In this talk, Dr. Siamak Daneshman reviewed the prior two abstracts (5006 and 5007) which looked at non-testicular cancer-related deaths in testicular cancer survivors, and clinical features of late relapse disease broken down by chemotherapy exposure and histology, respectively. He first provided his own timeline of major landmarks in germ cell tumor management.